Cardarine (GW501516) 20mg

$20.00

Chemical Information and Compositions of Cardarine (GW501516) 20mg

For researchers, biochemists, and wholesale distributors, the molecular structure of Cardarine is a masterpiece of targeted nuclear receptor agonism. Understanding its composition is vital for analytical testing, formulation, and predicting its biological behavior.

Official Chemical Nomenclature

  • IUPAC Name: 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid
  • Chemical Formula: C21H18F3NO3S2
  • Molecular Weight: 453.50 g/mol
  • CAS Number: 317318-29-3

Structural Composition Breakdown

Cardarine is a synthetic, small-molecule modulator. Its structural architecture is precisely tailored to fit the ligand-binding domain of the PPARδ receptor:

  1. The Trifluoromethylphenyl Group: The inclusion of a trifluoromethyl (-CF3) group on the distal phenyl ring is a classic medicinal chemistry optimization. Fluorine atoms are highly electronegative and increase the lipophilicity and metabolic stability of the molecule. This prevents rapid oxidative degradation by cytochrome P450 enzymes, ensuring a long biological half-life.
  2. The Thiazole Ring: A 1,3-thiazole heterocycle is fused into the core structure. This sulfur and nitrogen-containing ring is critical for the molecule’s conformational rigidity and its specific hydrogen-bonding interactions with the PPARδ receptor’s helix 12 (AF-2 domain), which is essential for receptor activation.
  3. The Methylsulfanyl Bridge: A sulfur atom links the thiazole ring to the phenoxy moiety. This thioether bond contributes to the molecule’s electron density and its precise spatial orientation within the receptor pocket.
  4. The Phenoxyacetic Acid Terminus: The acetic acid group at the end of the molecule is vital for solubility and for forming crucial ionic bonds with specific amino acid residues (like His323 and Tyr473) within the PPARδ binding pocket, anchoring the agonist securely.

Physical and Chemical Properties

  • State at Room Temperature: Solid (Crystalline Powder)
  • Color: White to off-white
  • Solubility: Practically insoluble in water; soluble in DMSO, PEG 400, ethanol, and methanol. Its poor aqueous solubility necessitates specific excipient matrices for oral capsule formulation.
  • Melting Point: Approximately 55°C to 58°C (Note: GW501516 has a relatively low and broad melting point, requiring careful handling during API synthesis and encapsulation to prevent degradation).

Pharmacokinetics

  • Route of Administration: Oral
  • Absorption: Rapidly and well absorbed from the gastrointestinal tract. Food does not significantly alter bioavailability.
  • Half-Life: The terminal elimination half-life of Cardarine in humans is approximately 12 to 24 hours. This long half-life allows for convenient once-daily dosing, maintaining stable PPARδ activation over a 24-hour period.
  • Metabolism: Primarily metabolized in the liver via CYP2C9 and CYP2C19, with minor contributions from CYP3A4.
  • Excretion: Excreted primarily via the feces through biliary elimination, with a small fraction excreted renally.

Formulation Details: The 20mg Capsule

When you source wholesale Cardarine 20mg, you are dealing with a formulation that bridges the gap between potent API and precise dosing.

A 20mg dose is the standard maximum research dose, equivalent to 0.020 grams. Standard excipients used in the encapsulation process include:

  • Microcrystalline Cellulose (MCC): Filler to provide bulk for precise encapsulation.
  • Magnesium Stearate: Lubricant to ensure smooth powder flow into capsule shells.
  • Hypromellose (HPMC): Often used for vegetarian capsule shells.

For B2B buyers, ensuring the uniform blending of 20mg of GW501516 API within the excipient matrix via geometric dilution is critical. Because GW501516 is a potent genetic modulator, “hot spots” (capsules containing 40mg+) in a poorly blended batch can drastically amplify the theoretical long-term risks associated with the compound.

SKU: N/A Category: